TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25753514

Group type: EXPERIMENTAL
Intervention: Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control side received laser treatment plus phototherapy
Number of subjects: 25
Study: 23450386

Group type: EXPERIMENTAL
Intervention: Psychosis risk label with accurate information
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Psychosis risk label without accurate information
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Schizophrenia label
Number of subjects: 153

Group type: COMPARATOR
Intervention: Nonpsychotic disorders (major depression, generalized anxiety disorder)
Number of subjects: 153
Study: 22093477

Group type: EXPERIMENTAL
Intervention: BIAsp 30
Number of subjects: 52

Group type: COMPARATOR
Intervention: BHI 30
Number of subjects: 52
Study: 19744725

Group type: EXPERIMENTAL
Intervention: Interferon (IFN)‐alfa‐2a treatment (3 MIU subcutaneously 3 times per week for 2 years)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (radiation or enucleation only)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Interferon (IFN)‐alfa‐2a treatment
Number of subjects: 121
Study: 16420531

Group type: EXPERIMENTAL
Intervention: Malignant melanomas
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Melanocytic nevi
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (non-lesional skin)
Number of subjects: 60
Study: 14765870

Group type: COMPARATOR
Intervention: Dermatomal quantitative sensory tests
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Decompressive surgery
Number of subjects: 27

Group type: COMPARATOR
Intervention: Low back pain assessment
Number of subjects: 27
Study: 11734652

Group type: EXPERIMENTAL
Intervention: Androgen ablative therapy
Number of subjects: 0
Study: 9148705

Group type: EXPERIMENTAL
Intervention: Epidural spinal cord stimulation (ESCS)
Number of subjects: 237
Study: 7584279

Group type: EXPERIMENTAL
Intervention: Younger subjects
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Older subjects
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Older-old subjects (> or = 70 years old)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Use of certain mnemonic strategies
Number of subjects: 12
Study: 3631181

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (n = 14)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (n = 12)
Number of subjects: 26
Study: 30785868

Group type: EXPERIMENTAL
Intervention: Moderate-to-high intensity aerobic exercise training (AET)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stretching/toning (ST) control intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical activity (combined AET and ST)
Number of subjects: 0
Study: 28446523

Group type: EXPERIMENTAL
Intervention: 10-week online parenting programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 0
Study: 25997425

Group type: EXPERIMENTAL
Intervention: High serum NT-proBNP level on hospital admission (≥ 2,563.6 pg/ml)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Non-ST-segment resolution (non-STR) group
Number of subjects: 218

Group type: COMPARATOR
Intervention: ST-segment resolution (STR) group
Number of subjects: 218
Study: 23538435

Group type: EXPERIMENTAL
Intervention: galyfilcon A/polyhexanide (combination 1)
Number of subjects: 37

Group type: COMPARATOR
Intervention: balafilcon A/polyquaternium‐1 and myristamidopropyl dimethylamine + TearGlyde (combination 2)
Number of subjects: 37
Study: 21615886

Group type: EXPERIMENTAL
Intervention: Indacaterol 150 μg
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Indacaterol 300 μg
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Indacaterol 600 μg
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Placebo/moxifloxacin
Number of subjects: 404

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 404
Study: 19384215

Group type: EXPERIMENTAL
Intervention: Nonobstructive 'quiet' family witness
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Family witness displaying an overt grief reaction
Number of subjects: 30

Group type: COMPARATOR
Intervention: No family witness
Number of subjects: 30
Study: 16699308

Group type: EXPERIMENTAL
Intervention: Iodine restricted group
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 81
Study: 15231461

Group type: EXPERIMENTAL
Intervention: Midazolam (5 mg)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Haloperidol (5 mg)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Lorazepam (2 mg)
Number of subjects: 111
Study: 12472345

Group type: EXPERIMENTAL
Intervention: 4% hydroquinone cream combined with glycolic acid peels
Number of subjects: 21

Group type: COMPARATOR
Intervention: 4% hydroquinone cream
Number of subjects: 21
Study: 9799140

Group type: EXPERIMENTAL
Intervention: Totally extraperitoneal endoscopic hernia operation (TEP)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Lichtenstein mesh repair (OPN)
Number of subjects: 45
Study: 7618930

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulphamethoxazole (TMP-SMX)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 2793706

Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 10
Study: 335795

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31880749

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure (VRE)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 104
Study: 30958285

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (3 sessions, once every 4-5 days)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Combined extracorporeal shock wave therapy (3 sessions, once every 4-5 days) and local use of silicone gel Strataderm
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no preventive measures)
Number of subjects: 29
Study: 28304227

Group type: EXPERIMENTAL
Intervention: Bococizumab 150 mg subcutaneously every 2 weeks
Number of subjects: 4300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4300

Group type: EXPERIMENTAL
Intervention: Bococizumab
Number of subjects: 4300
Study: 25442108

Group type: EXPERIMENTAL
Intervention: Intralesional cryosurgery
Number of subjects: 23

Group type: COMPARATOR
Intervention: Contact cryosurgery
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both cryosurgical methods
Number of subjects: 23
Study: 24787489

Group type: EXPERIMENTAL
Intervention: SGA
Number of subjects: 17046

Group type: COMPARATOR
Intervention: AGA
Number of subjects: 17046

Group type: EXPERIMENTAL
Intervention: LGA
Number of subjects: 17046

Group type: EXPERIMENTAL
Intervention: SGA with catch-up growth
Number of subjects: 17046
Study: 22928973

Group type: EXPERIMENTAL
Intervention: Active surveillance for low risk PCa
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Active surveillance for intermediate risk PCa
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Active surveillance for low and intermediate risk PCa
Number of subjects: 509
Study: 18814001

Group type: EXPERIMENTAL
Intervention: FLS expert rating
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Motion efficiency scores using ICSAD
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: FLS expert scores
Number of subjects: 26
Study: 17911777

Group type: EXPERIMENTAL
Intervention: Text classification augmented with a Hidden Markov Model
Number of subjects: 0
Study: 15545060

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid (800 microg of budesonide) for 12 weeks
Number of subjects: 45
Study: 11244659

Group type: EXPERIMENTAL
Intervention: Thermal balloon ablation therapy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Gestagen therapy
Number of subjects: 27
Study: 9850017

Group type: EXPERIMENTAL
Intervention: Short chemotherapy (6 months) with vincristine and dactinomycin (pulse-intensive)
Number of subjects: 905

Group type: EXPERIMENTAL
Intervention: Long chemotherapy (9 additional months) with vincristine and dactinomycin (pulse-intensive)
Number of subjects: 905

Group type: COMPARATOR
Intervention: Short PI treatment regimens
Number of subjects: 905
Study: 8116277

Group type: EXPERIMENTAL
Intervention: Non-informative cue presented at the same location as the target
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-informative cue remained on view throughout the period of the SOA and terminated 300 msec after target onset
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-informative cue with a duration of 130 msec
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targets in cued locations
Number of subjects: 0
Study: 30544793

Group type: EXPERIMENTAL
Intervention: Treatment group (received free vision care and eyeglasses)
Number of subjects: 2713

Group type: COMPARATOR
Intervention: Control group (received glasses only at the end of the study)
Number of subjects: 2713

Group type: EXPERIMENTAL
Intervention: Treatment group membership
Number of subjects: 2713
Study: 26758402

Group type: EXPERIMENTAL
Intervention: Captopril 1% ointment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 36
Study: 24987838

Group type: EXPERIMENTAL
Intervention: Quantitative computed tomography (CT) based texture analysis (QTA)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Kurtosis (QTA feature)
Number of subjects: 48
Study: 22230174

Group type: EXPERIMENTAL
Intervention: Bilingual program
Number of subjects: 188

Group type: COMPARATOR
Intervention: English-only program
Number of subjects: 188
Study: 19866403

Group type: EXPERIMENTAL
Intervention: 3 mg/kg of oral sildenafil every 6 hours
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo when the oxygenation index was >20
Number of subjects: 51
Study: 18416077

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for one month at main points (Zhongwan (CV 12), Zusanli (ST 36), Taichong (LR 3), Shenmen (HT 7))
Number of subjects: 80

Group type: COMPARATOR
Intervention: Domperidone orally administered for one month
Number of subjects: 80
Study: 16938781

Group type: EXPERIMENTAL
Intervention: Second identical cochlear implant in the contralateral ear immediately
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (waited 12 months)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Best-case scenario (no worsening of tinnitus)
Number of subjects: 24
Study: 14566831

Group type: EXPERIMENTAL
Intervention: Condom use (n = 68)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Noncondom use (n = 68)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: HPV-negative men (n not specified)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: HPV-positive men (n not specified)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Inconsistent HPV status men (n not specified)
Number of subjects: 136
Study: 10874273

Group type: EXPERIMENTAL
Intervention: Prodromal unstable angina
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Age, peak creatine kinase MB level, infarct location, combined variables
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group (no prodromal unstable angina)
Number of subjects: 196
Study: 8626363

Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 206

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 206
Study: 1452964

Group type: EXPERIMENTAL
Intervention: 400 mg dietary calcium per day
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 1,500 mg dietary calcium per day
Number of subjects: 13

Group type: COMPARATOR
Intervention: Baseline (low-calcium diet)
Number of subjects: 13
Study: 6531653

Group type: EXPERIMENTAL
Intervention: alprenolol (n = 20)
Number of subjects: 37

Group type: COMPARATOR
Intervention: placebo (n = 17)
Number of subjects: 37
Study: 29782272

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 0
Study: 28095578

Group type: EXPERIMENTAL
Intervention: BTL Vanquish METM
Number of subjects: 36

Group type: COMPARATOR
Intervention: VanquishTM
Number of subjects: 36
Study: 26591358

Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM) group - WYHZTLR decoction (one dose per day)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Western medicine (WM) group - penicillamine tablet (0.125 g, bid) and Prednisone Acetate Tablet (PAT 20 mg, qd)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Integrative medicine (IM) group - penicillamine, PAT, and WYHZTLR decoction (same dosages as above)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group - untreated SSc patients' serum
Number of subjects: 36
Study: 22917711

Group type: EXPERIMENTAL
Intervention: Armodafinil (150mg increased to 250mg after 4 weeks)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 20118171

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 1302

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 1302
Study: 19232061

Group type: EXPERIMENTAL
Intervention: New therapeutic interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Background therapy and/or early rescue
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Goals of remission and 'treating to targets'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive safety evaluation during randomized controlled trials
Number of subjects: 0
Study: 15689731

Group type: EXPERIMENTAL
Intervention: Computerized training of working memory (WM)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Comparison program (control)
Number of subjects: 53
Study: 12810749

Group type: EXPERIMENTAL
Intervention: Self-reported safety practices from a questionnaire
Number of subjects: 64

Group type: COMPARATOR
Intervention: Home safety check (observation)
Number of subjects: 64
Study: 10566728

Group type: EXPERIMENTAL
Intervention: SP-303 (500 mg p.o. every 6 h for 96 h)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 8729191

Group type: EXPERIMENTAL
Intervention: Tamoxifen (endocrine therapy)
Number of subjects: 0
Study: 1867617

Group type: EXPERIMENTAL
Intervention: 0.25% plain bupivacaine (local injection)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 0.25% plain bupivacaine (topical application)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.9% NaCl (control for local injection)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.9% NaCl (control for topical application)
Number of subjects: 80
Study: 6409958

Group type: EXPERIMENTAL
Intervention: Oral zinc load
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no zinc load)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: MS patients
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Erythrocyte membrane-bound CNP
Number of subjects: 72
Study: 29432041

Group type: EXPERIMENTAL
Intervention: Community paramedic training in the CTI program, geriatrics, effective coaching, ED discharge processes, and community paramedicine.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Community paramedic training in the CTI program.
Number of subjects: 8
Study: 26876351

Group type: EXPERIMENTAL
Intervention: PRGF (n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PRF (n = 10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (bone-substitute grafting, n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 30
Study: 24927851

Group type: EXPERIMENTAL
Intervention: Group follow-up (two group education 'booster' sessions post-DAFNE)
Number of subjects: 437
Study: 22661076

Group type: EXPERIMENTAL
Intervention: Prospectively ECG-triggered axial acquisition
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Prospectively ECG-triggered high pitch spiral acquisition
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Standard spiral acquisition
Number of subjects: 150
Study: 19758763

Group type: EXPERIMENTAL
Intervention: Cognitive intervention (CI) prior to injection with CRH
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CRH stimulation
Number of subjects: 32
Study: 18408924

Group type: EXPERIMENTAL
Intervention: 3D TrueFISP
Number of subjects: 10

Group type: COMPARATOR
Intervention: PD-FS-TSE
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Quantitative T2 mapping
Number of subjects: 10
Study: 16913455

Group type: EXPERIMENTAL
Intervention: School curriculum intervention on HIV/AIDS/STD prevention including emergency contraception (EC) information.
Number of subjects: 11117
Study: 14504028

Group type: EXPERIMENTAL
Intervention: BUP 8 mg s.l. tablet
Number of subjects: 5

Group type: COMPARATOR
Intervention: METH 60 mg/day
Number of subjects: 5
Study: 11106097

Group type: EXPERIMENTAL
Intervention: 15 microg CIFN
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: 9 microg CIFN
Number of subjects: 187

Group type: COMPARATOR
Intervention: 3 MU IFN-alpha-2a
Number of subjects: 187
Study: 9347392

Group type: EXPERIMENTAL
Intervention: Amineptine (200 mg per day)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 284
Study: 8327705

Group type: EXPERIMENTAL
Intervention: Liquid contrast material
Number of subjects: 101

Group type: COMPARATOR
Intervention: Air contrast material
Number of subjects: 101
Study: 3027832

Group type: EXPERIMENTAL
Intervention: 50 mg of itraconazole daily
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: 100 mg of itraconazole daily
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: 50 mg or 100 mg of itraconazole daily
Number of subjects: 185
Study: 29484877

Group type: EXPERIMENTAL
Intervention: Neurologic music therapy for 16 weeks in addition to usual physiotherapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Usual therapeutic input without neurologic music therapy
Number of subjects: 18
Study: 27706199

Group type: EXPERIMENTAL
Intervention: Shared Positive Outcome Ratio (SPOR) based on patient satisfaction
Number of subjects: 574

Group type: EXPERIMENTAL
Intervention: High-scoring group of providers
Number of subjects: 574

Group type: COMPARATOR
Intervention: Low-scoring group of providers
Number of subjects: 574
Study: 24132773

Group type: EXPERIMENTAL
Intervention: 75 mg soft-gel capsule of acetylsalicylic acid (ASA)
Number of subjects: 46

Group type: COMPARATOR
Intervention: marketed powder for oral solution
Number of subjects: 46
Study: 21850506

Group type: COMPARATOR
Intervention: TVT
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: TVT-O
Number of subjects: 177
Study: 21626815

Group type: EXPERIMENTAL
Intervention: Akatinol memantine (5-10 mg/day, increased to 20 mg/day over 90 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Neurorehabilitation without akatinol memantine (control group)
Number of subjects: 50
Study: 17592907

Group type: EXPERIMENTAL
Intervention: Adjunctive aripiprazole (2-15 mg/day with fluoxetine or paroxetine; 2-20 mg/day with all others)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Adjunctive placebo
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Adjunctive aripiprazole
Number of subjects: 362
Study: 15912413

Group type: EXPERIMENTAL
Intervention: Neostigmine (500 mug)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Morphine (2 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tenoxicam (20 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Clonidine (1 microg kg(‐1))
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Bupivacaine (100 mg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Saline (20 ml)
Number of subjects: 150
Study: 11836043

Group type: EXPERIMENTAL
Intervention: 1 mg E2/0.5 mg NETA (low-dose HRT)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 2 mg E2/1 mg NETA (high-dose HRT)
Number of subjects: 96
Study: 10616118

Group type: EXPERIMENTAL
Intervention: Maintenance of Wakefulness Test (MWT)
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Epworth Sleepiness Scale (ESS)
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Multiple Sleep Latency Test (MSLT)
Number of subjects: 522
Study: 7488481

Group type: EXPERIMENTAL
Intervention: 100% oxygen
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oxygen-air mixture
Number of subjects: 30
Study: 2023370

Group type: EXPERIMENTAL
Intervention: 0.25% Bupranolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.5% Timolol (preserved)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Beta-blockers in aqueous solution
Number of subjects: 0
Study: 6758748

Group type: EXPERIMENTAL
Intervention: Tetanus toxoid
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Candida albicans
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tetanus toxoid and Candida albicans
Number of subjects: 60
Study: 31990800

Group type: EXPERIMENTAL
Intervention: Removal of catheter immediately after surgery (group 1)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Standard overnight indwelling urethral catheterization (group 2)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 73
Study: 31804186

Group type: EXPERIMENTAL
Intervention: Web-based self-titration program
Number of subjects: 222

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 222
Study: 27435635

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Intervention (CBI) for 5 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 26446331

Group type: EXPERIMENTAL
Intervention: 0.5 g/kg of 20% intravenous mannitol infusion over 10 minutes before induction of anesthesia (group M)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (group C)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.5 g/kg of 20% intravenous mannitol infusion (group M)
Number of subjects: 40
Study: 24145068

Group type: EXPERIMENTAL
Intervention: Mobile bearing total knee arthroplasty
Number of subjects: 352

Group type: COMPARATOR
Intervention: Fixed bearing total knee arthroplasty
Number of subjects: 352
Study: 22455791

Group type: EXPERIMENTAL
Intervention: Chloramphenicol 0.5%‐dexamethasone 0.1% plus diclofenac 0.1%, 1 drop 3 times a day, plus diclofenac 0.1% for 3 days before surgery (n=38)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Chloramphenicol 0.5%‐dexamethasone 0.1%, 1 drop 4 times a day (n=41)
Number of subjects: 79